Giapreza

Chemical Nameangiotensin II
Dosage FormInjection (intravenous; 2.5 mg/mL)
Drug ClassHormones
SystemCardiovascular
CompanyLa Jolla Pharma
Approval Year2017

Indication

  • Indicated to increase blood pressure in adults with septic or other distributive shock.
Last updated on 9/9/2022

More on this drug: Clinical Trials

Document TitleYearSource
Giapreza (angiotensin II) Prescribing Information.2020La Jolla Pharmaceutical Company, San Diego, CA

Have we missed a study, or would you like to comment on a study?